Skip to main content
Bevan Tandon, MD, Pathology, Chicago, IL

BevanTandonMD

Pathology Chicago, IL

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Physician

Dr. Tandon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tandon's full profile

Already have an account?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematopathology, 2012 - 2014
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Pathology-Anatomic and Clinical, 2008 - 2012
  • University of California (Irvine)
    University of California (Irvine)Residency, Pathology-Anatomic and Clinical, 2008 - 2008
  • Eastern Virginia Medical School
    Eastern Virginia Medical SchoolClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2026
  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • GA State Medical License
    GA State Medical License 2015 - 2023
  • TN State Medical License
    TN State Medical License 2015 - 2022
  • KY State Medical License
    KY State Medical License 2015 - 2021
  • SC State Medical License
    SC State Medical License 2015 - 2021
  • NC State Medical License
    NC State Medical License 2015 - 2020
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Pathology - Molecular Genetic
  • American Board of Pathology Hematopathology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial
    OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical TrialAugust 28th, 2018